# Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns ![Abstract pharmacology study cover showing an unmarked capsule and tablet encircled by six colorful receptor, channel, enzyme, and signaling motifs on a navy field\.]() Study 126 cards on 30 common drug classes: mechanisms, qualified generic\-name patterns, common uses, and major safety concepts for nursing and introductory health science\. Автор [Open Study Contributor]() [Изучать эту колоду бесплатно]() Откроется Nibomo, и вы сможете начать изучение\. ## Сведения о колоде - Карточки: 126 карточек - Версия: 1 - Опубликовано: 31 августа 2026 г. - Последнее обновление: 10 сентября 2026 г. - Лицензия: Common knowledge · CC0 1\.0 - Языки аудитории: [en]() - Предмет: Pharmacology - Теги: pharmacology, cardio\-renal, neuro\-psych, diabetes\-metabolic, anti\-infective, respiratory\-gi, pain\-immune > **Предупреждение о содержании:** Educational study material only; not for clinical decision\-making, prescribing, dosing, or patient\-specific guidance\. ## Об этой колоде Build a durable pharmacology map with 126 independently authored cards. Six prerequisites define drug classes, mechanisms, agonism, antagonism, inhibition, and how to treat generic-name stems as fallible clues. The remaining 120 cards cover 30 common classes through four separate retrieval directions: class → core mechanism; qualified pattern or representative generics → class; class → common use; and class → major safety concept. The deck deliberately excludes dosing, prescribing, patient-specific guidance, administration or hold parameters, exhaustive contraindications and interactions, monitoring protocols, brand names, official questions, and clinical cases. Generic-name patterns are clues, never universal rules. Use this deck for study—not clinical decision-making. Ordering supports learning: prerequisites come first, then five spiral blocks mix six broad topic groups. Same-class variants stay at least three unrelated cards apart, alternating mechanism, recognition, common-use, and safety recall instead of forming predictable runs. Open Study Contributor independently authored this standalone deck from common pharmacology knowledge checked against WHO, FDA, and NIH/NCBI sources. Organization names identify sources only; no affiliation or endorsement is claimed. ## Похожие колоды - [Coding Interview Patterns Flashcards: Signals, Invariants & Complexity]() - [Recurring Decimals to Fractions Flashcards: Patterns & Algebra]() - [Common Network Port Numbers Flashcards: Protocols, TCP/UDP & Uses]() - [Medical Abbreviation Flashcards: Common Clinical Terms & Acronyms]() ## Карточки в этой колоде ### Карточка 1 **Вопрос** What is a drug class? **Ответ** A group of drugs linked by a shared mechanism, target, structure, therapeutic use, or a combination of these features. ### Карточка 2 **Вопрос** What does mechanism of action mean? **Ответ** How a drug produces its effects at a molecular, cellular, or physiological target. ### Карточка 3 **Вопрос** What is a receptor agonist? **Ответ** A drug that binds to a receptor and activates it to produce a response. ### Карточка 4 **Вопрос** What is a receptor antagonist? **Ответ** A drug that binds to a receptor and blocks or reduces activation by an agonist. ### Карточка 5 **Вопрос** What does it mean when a drug inhibits an enzyme or transporter? **Ответ** It reduces that protein's activity, changing the movement or conversion of its usual substrates. ### Карточка 6 **Вопрос** How should generic-name stems be used to recognize drug classes? **Ответ** As clues, not universal rules. Confirm the actual drug because exceptions and overlapping stems exist. ### Карточка 7 **Вопрос** ACE inhibitors: core mechanism? **Ответ** They inhibit angiotensin-converting enzyme, reducing angiotensin II and aldosterone while increasing bradykinin. ### Карточка 8 **Вопрос** SSRIs: core mechanism? **Ответ** They inhibit the serotonin transporter, increasing serotonin signaling in the synaptic cleft. ### Карточка 9 **Вопрос** Biguanides: core mechanism? **Ответ** Metformin mainly reduces hepatic glucose production and improves insulin sensitivity without directly stimulating insulin release. ### Карточка 10 **Вопрос** Penicillins: core mechanism? **Ответ** Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis. ### Карточка 11 **Вопрос** Which class is often suggested by the ending -pril? **Ответ** ACE inhibitors. Examples include lisinopril and enalapril, but a name stem is only a clue. ### Карточка 12 **Вопрос** Proton-pump inhibitors: core mechanism? **Ответ** They inhibit the H+/K+ ATPase proton pump in gastric parietal cells, strongly reducing acid secretion. ### Карточка 13 **Вопрос** SSRIs: common uses? **Ответ** Depression and several anxiety-related disorders; the approved indications differ by agent. ### Карточка 14 **Вопрос** NSAIDs: core mechanism? **Ответ** They inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis. ### Карточка 15 **Вопрос** Biguanides: major safety concepts? **Ответ** Gastrointestinal effects are common; vitamin B12 can fall with long use, and lactic acidosis is rare but serious. ### Карточка 16 **Вопрос** Which class is often suggested by the ending -cillin? **Ответ** Penicillins, such as amoxicillin and piperacillin. The stem does not describe spectrum or resistance. ### Карточка 17 **Вопрос** ACE inhibitors: common uses? **Ответ** Hypertension and selected heart-failure, post-myocardial-infarction, and kidney-protection indications. ### Карточка 18 **Вопрос** Proton-pump inhibitors: major safety concepts? **Ответ** Possible concerns include hypomagnesemia and enteric infection risk. Many other long-term links are observational rather than proven causal effects. ### Карточка 19 **Вопрос** Which class is often suggested by -oxetine or -opram? **Ответ** SSRIs, but not universally. Sertraline and fluvoxamine are exceptions, and some stems overlap other classes. ### Карточка 20 **Вопрос** NSAIDs: common uses? **Ответ** Pain, inflammation, and fever; individual agents also have more specific uses. ### Карточка 21 **Вопрос** Metformin belongs to which drug class? **Ответ** Biguanides. Metformin is the main widely used member, so there is no useful class-wide suffix rule. ### Карточка 22 **Вопрос** Penicillins: major safety concepts? **Ответ** Hypersensitivity can range from rash to anaphylaxis; diarrhea and antibiotic-associated colitis are additional concerns. ### Карточка 23 **Вопрос** ACE inhibitors: major safety concepts? **Ответ** Cough, hyperkalemia, kidney-function changes, angioedema, and fetal harm are major class concerns. ### Карточка 24 **Вопрос** Proton-pump inhibitors: common uses? **Ответ** Acid-related disorders such as GERD, erosive esophagitis, and peptic-ulcer disease. ### Карточка 25 **Вопрос** SSRIs: major safety concepts? **Ответ** Serotonin syndrome, bleeding and hyponatremia risks, sexual dysfunction, and the antidepressant suicidality warning for younger people. ### Карточка 26 **Вопрос** Ibuprofen, naproxen, and ketorolac belong to which class? **Ответ** NSAIDs. The class has no single reliable generic-name suffix. ### Карточка 27 **Вопрос** Biguanides: common use? **Ответ** Type 2 diabetes. ### Карточка 28 **Вопрос** Penicillins: common use? **Ответ** Treatment of susceptible bacterial infections; the spectrum differs substantially among individual penicillins. ### Карточка 29 **Вопрос** Which class is often suggested by the ending -prazole? **Ответ** Proton-pump inhibitors, such as omeprazole and pantoprazole. Confirm the individual drug. ### Карточка 30 **Вопрос** NSAIDs: major safety concepts? **Ответ** Gastrointestinal bleeding, kidney injury, fluid retention, and cardiovascular events are key risks; FDA also warns about use from about 20 weeks of pregnancy. ### Карточка 31 **Вопрос** Sulfonylureas: core mechanism? **Ответ** They close ATP-sensitive potassium channels in pancreatic beta cells, triggering insulin release even when glucose is not high. ### Карточка 32 **Вопрос** H2 blockers: core mechanism? **Ответ** They competitively block histamine H2 receptors on gastric parietal cells, reducing acid secretion. ### Карточка 33 **Вопрос** SNRIs: core mechanism? **Ответ** They inhibit serotonin and norepinephrine reuptake transporters, increasing both transmitters in synapses. ### Карточка 34 **Вопрос** Opioid analgesics: core mechanism? **Ответ** They activate opioid receptors; many important analgesic effects and toxicities are mediated through mu receptors. ### Карточка 35 **Вопрос** Glipizide, glyburide, and glimepiride belong to which class? **Ответ** Sulfonylureas. Their names offer clues, but the broad ending -ide is not class-specific. ### Карточка 36 **Вопрос** ARBs: core mechanism? **Ответ** They block angiotensin II at AT1 receptors, reducing vasoconstriction and aldosterone effects. ### Карточка 37 **Вопрос** H2 blockers: common uses? **Ответ** Acid-related disorders such as heartburn, GERD, and gastric or duodenal ulcers. ### Карточка 38 **Вопрос** Cephalosporins: core mechanism? **Ответ** Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis. ### Карточка 39 **Вопрос** SNRIs: major safety concepts? **Ответ** Serotonin syndrome, blood-pressure increases, discontinuation symptoms, and the antidepressant suicidality warning for younger people. ### Карточка 40 **Вопрос** Morphine, oxycodone, and fentanyl belong to which broad class? **Ответ** Opioid analgesics. The class has no single reliable generic-name suffix. ### Карточка 41 **Вопрос** Sulfonylureas: common use? **Ответ** Type 2 diabetes when increasing pancreatic insulin release is appropriate. ### Карточка 42 **Вопрос** ARBs: major safety concepts? **Ответ** Hyperkalemia, hypotension, kidney-function changes, and fetal harm are major concerns; cough is less common than with ACE inhibitors. ### Карточка 43 **Вопрос** Which class is often suggested by the ending -tidine? **Ответ** H2 receptor blockers, such as famotidine and cimetidine. Confirm the individual drug. ### Карточка 44 **Вопрос** Cephalosporins: common use? **Ответ** Treatment of susceptible bacterial infections; antibacterial spectrum varies widely by agent and generation. ### Карточка 45 **Вопрос** Which name endings can suggest an SNRI? **Ответ** -faxine or sometimes -oxetine, but neither is decisive. The -oxetine ending also appears in some SSRIs. ### Карточка 46 **Вопрос** Opioid analgesics: major safety concepts? **Ответ** Respiratory depression, sedation, constipation, tolerance, dependence, and overdose; benzodiazepines and other depressants increase danger. ### Карточка 47 **Вопрос** Sulfonylureas: major safety concepts? **Ответ** Hypoglycemia and weight gain are the main class patterns, with risk differing among agents and clinical contexts. ### Карточка 48 **Вопрос** ARBs: common uses? **Ответ** Hypertension and selected heart-failure and kidney-protection indications. ### Карточка 49 **Вопрос** H2 blockers: major safety concepts? **Ответ** They are usually well tolerated, but confusion or other CNS effects can occur with reduced clearance; cimetidine has many interactions. ### Карточка 50 **Вопрос** Which class is often suggested by cef- or ceph-? **Ответ** Cephalosporins, such as cefazolin and cephalexin. The name does not reveal the full spectrum. ### Карточка 51 **Вопрос** SNRIs: common uses? **Ответ** Depression and anxiety disorders; selected agents also treat neuropathic pain or fibromyalgia. ### Карточка 52 **Вопрос** Opioid analgesics: common uses? **Ответ** Analgesia for selected severe pain and perioperative settings; individual opioids also have other specific uses. ### Карточка 53 **Вопрос** Which class is often suggested by the ending -sartan? **Ответ** Angiotensin II receptor blockers, or ARBs. Examples include losartan and valsartan. ### Карточка 54 **Вопрос** Cephalosporins: major safety concepts? **Ответ** Hypersensitivity and antibiotic-associated diarrhea are important; penicillin cross-reactivity depends largely on similar side chains. ### Карточка 55 **Вопрос** Beta2 agonists: core mechanism? **Ответ** They activate beta2 receptors, increasing cAMP and relaxing airway smooth muscle. ### Карточка 56 **Вопрос** Beta blockers: core mechanism? **Ответ** They antagonize beta-adrenergic receptors; beta1 blockade can reduce heart rate, contractility, and renin release. ### Карточка 57 **Вопрос** Systemic corticosteroids: core mechanism? **Ответ** They bind intracellular glucocorticoid receptors and alter gene transcription, reducing inflammatory and immune signaling. ### Карточка 58 **Вопрос** Benzodiazepines: core mechanism? **Ответ** They positively modulate GABA-A receptors, increasing the frequency of chloride-channel opening when GABA is present. ### Карточка 59 **Вопрос** Which class is often suggested by the ending -terol? **Ответ** Beta2 agonist bronchodilators, such as formoterol and salmeterol. Albuterol is a familiar exception. ### Карточка 60 **Вопрос** Macrolides: core mechanism? **Ответ** They bind the bacterial 50S ribosomal subunit and inhibit protein synthesis. ### Карточка 61 **Вопрос** Beta blockers: common uses? **Ответ** Selected cardiovascular conditions such as arrhythmias, ischemic heart disease, heart failure, and hypertension; some agents have noncardiac uses. ### Карточка 62 **Вопрос** GLP-1 receptor agonists: core mechanism? **Ответ** They activate GLP-1 receptors, increasing glucose-dependent insulin release, suppressing glucagon, and slowing gastric emptying. ### Карточка 63 **Вопрос** Systemic corticosteroids: major safety concepts? **Ответ** Infection, hyperglycemia, osteoporosis, and hypothalamic-pituitary-adrenal suppression; risks rise with systemic exposure and duration. ### Карточка 64 **Вопрос** Which endings often suggest a benzodiazepine? **Ответ** -azepam or -azolam, as in diazepam or midazolam. Not every sedative with a similar ending belongs to this class. ### Карточка 65 **Вопрос** Beta2 agonists: common use? **Ответ** Bronchodilation in asthma or COPD regimens; short- and long-acting agents play different roles. ### Карточка 66 **Вопрос** Macrolides: major safety concepts? **Ответ** Gastrointestinal effects, QT prolongation, and clinically important interactions that vary by agent. ### Карточка 67 **Вопрос** Which class is often suggested by the ending -olol? **Ответ** Beta blockers, such as metoprolol and propranolol. Receptor selectivity still varies by agent. ### Карточка 68 **Вопрос** GLP-1 receptor agonists: common uses? **Ответ** Type 2 diabetes; selected agents are also approved for chronic weight management and cardiovascular-risk reduction. ### Карточка 69 **Вопрос** Which patterns often suggest a systemic corticosteroid? **Ответ** -sone or -olone, as in prednisone or prednisolone, but these endings are not unique to the class. ### Карточка 70 **Вопрос** Benzodiazepines: major safety concepts? **Ответ** Sedation, dependence and withdrawal, plus respiratory depression—especially with opioids, alcohol, or other CNS depressants. ### Карточка 71 **Вопрос** Beta2 agonists: major safety concepts? **Ответ** Tremor, palpitations or tachycardia, hypokalemia, and rare paradoxical bronchospasm. ### Карточка 72 **Вопрос** Macrolides: common use? **Ответ** Treatment of selected susceptible bacterial infections, including some respiratory and atypical pathogens. ### Карточка 73 **Вопрос** Beta blockers: major safety concepts? **Ответ** Bradycardia and hypotension; nonselective agents can cause bronchospasm, and the class can mask adrenergic signs of hypoglycemia. ### Карточка 74 **Вопрос** Which class is often suggested by -glutide? **Ответ** GLP-1 receptor agonists, such as semaglutide and liraglutide. Exenatide and lixisenatide show the pattern is not universal. ### Карточка 75 **Вопрос** Systemic corticosteroids: common uses? **Ответ** Inflammatory, allergic, and autoimmune disorders, with the route and agent chosen for the condition. ### Карточка 76 **Вопрос** Benzodiazepines: common uses? **Ответ** Anxiety, seizures, procedural sedation, or alcohol withdrawal, depending on the agent and setting. ### Карточка 77 **Вопрос** Which class is often suggested by the ending -thromycin? **Ответ** Macrolide antibiotics, such as azithromycin and clarithromycin. Confirm the individual agent. ### Карточка 78 **Вопрос** GLP-1 receptor agonists: major safety concepts? **Ответ** Gastrointestinal effects are common; gallbladder disease and pancreatitis are warnings, and some labels warn about thyroid C-cell tumors. ### Карточка 79 **Вопрос** Second-generation antipsychotics: core mechanism? **Ответ** Most modulate dopamine D2 and serotonin 5-HT2A signaling, but receptor profiles vary substantially by agent. ### Карточка 80 **Вопрос** Tetracyclines: core mechanism? **Ответ** They bind the bacterial 30S ribosomal subunit and inhibit protein synthesis. ### Карточка 81 **Вопрос** Dihydropyridine calcium-channel blockers: core mechanism? **Ответ** They block L-type calcium channels mainly in vascular smooth muscle, causing arteriolar relaxation. ### Карточка 82 **Вопрос** Inhaled antimuscarinics: core mechanism? **Ответ** They block airway muscarinic receptors, reducing vagal bronchoconstriction and promoting bronchodilation. ### Карточка 83 **Вопрос** Which endings often suggest a second-generation antipsychotic? **Ответ** -apine or -idone often appear, but many members use other endings and the stems are not class-specific. ### Карточка 84 **Вопрос** SGLT2 inhibitors: core mechanism? **Ответ** They inhibit renal sodium-glucose cotransporter 2, increasing urinary glucose and sodium excretion. ### Карточка 85 **Вопрос** Tetracyclines: common uses? **Ответ** Selected susceptible bacterial infections and, for some agents, acne or rosacea. ### Карточка 86 **Вопрос** Bisphosphonates: core mechanism? **Ответ** They bind bone mineral and inhibit osteoclast-mediated bone resorption. ### Карточка 87 **Вопрос** Dihydropyridine calcium-channel blockers: major safety concepts? **Ответ** Peripheral edema, flushing, headache, dizziness, and hypotension are characteristic patterns. ### Карточка 88 **Вопрос** Which class is often suggested by the ending -tropium? **Ответ** Inhaled antimuscarinic bronchodilators, such as ipratropium and tiotropium. Several class members use other endings. ### Карточка 89 **Вопрос** Second-generation antipsychotics: common uses? **Ответ** Schizophrenia and selected bipolar or other psychiatric indications; approvals differ by agent. ### Карточка 90 **Вопрос** SGLT2 inhibitors: major safety concepts? **Ответ** Genital infections, volume depletion, ketoacidosis, and rare necrotizing infection of the perineum. ### Карточка 91 **Вопрос** Which class is often suggested by the ending -cycline? **Ответ** Tetracycline antibiotics, such as doxycycline and minocycline. Confirm the individual drug. ### Карточка 92 **Вопрос** Bisphosphonates: common uses? **Ответ** Osteoporosis and selected disorders with excessive bone resorption, including Paget disease or malignancy-related bone disease. ### Карточка 93 **Вопрос** Which class is often suggested by the ending -dipine? **Ответ** Dihydropyridine calcium-channel blockers, such as amlodipine and nifedipine. ### Карточка 94 **Вопрос** Inhaled antimuscarinics: major safety concepts? **Ответ** Dry mouth, urinary retention, tachycardia, and eye exposure that may worsen narrow-angle glaucoma. ### Карточка 95 **Вопрос** Second-generation antipsychotics: major safety concepts? **Ответ** Metabolic effects, movement disorders, QT effects, and neuroleptic malignant syndrome; labels warn about increased mortality in elderly patients with dementia-related psychosis. ### Карточка 96 **Вопрос** SGLT2 inhibitors: common uses? **Ответ** Type 2 diabetes; selected agents also treat heart failure or chronic kidney disease. ### Карточка 97 **Вопрос** Tetracyclines: major safety concepts? **Ответ** Gastrointestinal or esophageal irritation, photosensitivity, and effects on developing teeth and bone are key patterns. ### Карточка 98 **Вопрос** Which class is often suggested by the ending -dronate? **Ответ** Bisphosphonates, such as alendronate and risedronate. Confirm the individual agent and formulation. ### Карточка 99 **Вопрос** Dihydropyridine calcium-channel blockers: common uses? **Ответ** Hypertension and angina, using vascular smooth-muscle relaxation to reduce arterial tone. ### Карточка 100 **Вопрос** Inhaled antimuscarinics: common use? **Ответ** Maintenance bronchodilation, especially in COPD; selected agents also serve as add-on asthma therapy. ### Карточка 101 **Вопрос** Which class is often suggested by the ending -gliflozin? **Ответ** SGLT2 inhibitors, such as empagliflozin and dapagliflozin. ### Карточка 102 **Вопрос** Bisphosphonates: major safety concepts? **Ответ** Upper-GI irritation with oral agents, hypocalcemia, and rare osteonecrosis of the jaw or atypical femur fracture. ### Карточка 103 **Вопрос** TNF inhibitors: core mechanism? **Ответ** They neutralize tumor necrosis factor signaling, reducing downstream inflammation. ### Карточка 104 **Вопрос** DPP-4 inhibitors: core mechanism? **Ответ** They inhibit DPP-4, prolonging endogenous incretin activity and increasing glucose-dependent insulin release. ### Карточка 105 **Вопрос** Inhaled corticosteroids: core mechanism? **Ответ** They activate glucocorticoid receptors in airway cells, reducing inflammatory gene expression and airway inflammation. ### Карточка 106 **Вопрос** Statins: core mechanism? **Ответ** They inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing hepatic LDL-receptor activity. ### Карточка 107 **Вопрос** Adalimumab, infliximab, and etanercept belong to which class? **Ответ** TNF inhibitors. The class has no single specific shared suffix: -mab is broad, and etanercept ends in -cept. ### Карточка 108 **Вопрос** Triptans: core mechanism? **Ответ** They activate serotonin 5-HT1B/1D receptors, reducing trigeminal signaling and causing cranial vasoconstriction. ### Карточка 109 **Вопрос** DPP-4 inhibitors: common use? **Ответ** Type 2 diabetes, using enhanced endogenous incretin signaling to improve glucose-dependent insulin release. ### Карточка 110 **Вопрос** Fluoroquinolones: core mechanism? **Ответ** They inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication. ### Карточка 111 **Вопрос** Inhaled corticosteroids: major safety concepts? **Ответ** Oral candidiasis and dysphonia are important local effects; systemic effects become more relevant with higher exposure. ### Карточка 112 **Вопрос** Which class is suggested by the ending -statin? **Ответ** HMG-CoA reductase inhibitors, or statins, such as atorvastatin and rosuvastatin. ### Карточка 113 **Вопрос** TNF inhibitors: common uses? **Ответ** Selected autoimmune inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis-related conditions. ### Карточка 114 **Вопрос** Triptans: major safety concepts? **Ответ** Vasoconstrictive risk in coronary, cerebrovascular, or peripheral vascular disease, plus tingling, flushing, or chest pressure called triptan sensations. ### Карточка 115 **Вопрос** Which class is suggested by the ending -gliptin? **Ответ** DPP-4 inhibitors, such as sitagliptin and linagliptin. ### Карточка 116 **Вопрос** Fluoroquinolones: common use? **Ответ** Selected serious or resistant bacterial infections when their spectrum and risk profile fit the infection. ### Карточка 117 **Вопрос** Which patterns often suggest an inhaled corticosteroid? **Ответ** -sonide or -sone often appear, as in budesonide or fluticasone, but these endings are not class-specific. ### Карточка 118 **Вопрос** Statins: major safety concepts? **Ответ** Muscle symptoms and rare rhabdomyolysis or liver injury; pregnancy is a major risk context, although FDA no longer applies a blanket class contraindication. ### Карточка 119 **Вопрос** TNF inhibitors: major safety concepts? **Ответ** Serious infections and reactivation of tuberculosis or hepatitis B are central concerns; other warnings vary by agent. ### Карточка 120 **Вопрос** Triptans: common use? **Ответ** Acute treatment of migraine attacks; they are not general-purpose analgesics or routine migraine preventives. ### Карточка 121 **Вопрос** DPP-4 inhibitors: major safety concepts? **Ответ** Severe joint pain and pancreatitis are warnings; some agents also carry a heart-failure warning. ### Карточка 122 **Вопрос** Which class is suggested by the ending -floxacin? **Ответ** Fluoroquinolone antibiotics, such as ciprofloxacin and levofloxacin. ### Карточка 123 **Вопрос** Inhaled corticosteroids: common use? **Ответ** Controller therapy for asthma and selected COPD regimens; they reduce inflammation rather than acting as standalone rescue bronchodilators. ### Карточка 124 **Вопрос** Statins: common uses? **Ответ** Lowering LDL cholesterol and reducing atherosclerotic cardiovascular risk. ### Карточка 125 **Вопрос** Which class is suggested by the ending -triptan? **Ответ** Triptan antimigraine agents, such as sumatriptan and rizatriptan. ### Карточка 126 **Вопрос** Fluoroquinolones: major safety concepts? **Ответ** Potentially disabling tendon, muscle, joint, nerve, and CNS effects, plus a rare risk of aortic aneurysm or rupture in susceptible people. --- *[Открыть оформленную HTML\-версию этой страницы]()* *ИИ-агенты могут создать аккаунт пользователя в этом сервисе, начиная с `GET https://api.nibomo.com/v1/`. После настройки они также могут подключиться по MCP по адресу `https://mcp.nibomo.com/mcp`.* *Совет: добавьте `.md` к любому URL на https://nibomo.com, чтобы получить чистую Markdown-версию страницы.*